The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think the p75 uh receptor uh agonist or amplifier looks pretty promising. Those studies are ongoing. uh and then you know for prevention I think some of these things the uh antibodies do have applications but they also come with a lot of baggage with uh not only the cost and accessibility but cerebral hemorrhage
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
You know, uh there's been not a whole lot of movement there. We have the antibodies. You know, you go to antibody therapy, you're talking 50k at least, you know, hundreds of thousands of dollars. You have the potential for side effects like cerebral hemorrhage and things like that. And they move the needle maybe for prevention.